ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2729

Increased Risk of Cerebrovascular Accident Among Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review and Meta-Analysis of Cohort Studies

Patompong Ungprasert1, Karn Wijarnpreecha2 and Wisit Cheungpasitporn3, 1Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Internal medicine, Bassett medical center, cooperstown, NY, 3Medicine, University of Mississippi Medical center, Jackson, MS

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ANCA, Cardiovascular disease, epidemiologic methods and meta-analysis, Wegener's granulomatosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Vasculitis – ANCA-Associated Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Increased Risk of Cerebrovascular Accident among Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review and Meta-analysis of Cohort Studies

Abstract

Background/Purpose: An increased risk of cardiovascular disease, including cerebrovascular accident (CVA), among patients with chronic inflammatory immune-mediated disorders is well-recognized, especially among patients with rheumatoid arthritis and systemic lupus erythematosus.  Patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) may be at an increased risk of CVA as well although the data are still inconclusive as most studies addressing this association were small in size.  The current systematic review and meta-analysis was conducted with the aims to identify all relevant studies and summarize their results together.

Methods: Two investigators independently searched for published studies indexed in MEDLINE and EMBASE database from inception to April 2018 using the search strategy that included the terms for anti-neutrophil cytoplasmic antibody-associated vasculitis and cerebrovascular accident.  Eligible studies were cohort studies (either retrospective or prospective) that compared the risk of incident CVA between patients with AAV and individuals without AAV.  They must also report the relative risk or hazard ratio with 95% confidence intervals (CI) of this comparison.  Point estimates and standard errors from each study were extracted and combined together using the random effect, generic inverse variance technique of DerSimonian and Laird.  Evaluation for publication bias was conducted using funnel plot.

Results: Of 1,132 retrieved articles, a total of 5 studies fulfilled the inclusion criteria and were included in this meta-analysis.  The risk of incident CVA among patients with AAV was significantly higher than individuals without AAV with the pooled risk ratio of 1.49 (95% CI, 1.06–2.10).  The statistical heterogeneity was insignificant with an I2 of 11%.  The forest plot of this meta-analysis is shown as figure 1.  The funnel plot (figure 2) of this study was relatively symmetric and did not suggest the presence of publication although the interpretation was limited by the relatively low number of included studies.

Conclusion:  A significantly increased risk of cerebrovascular accident among patients with anti-neutrophil cytoplasmic antibody-associated vasculitis was observed in this study.

Figure 1: Forest plot of this meta-analysis

Figure 2: Funnel plot of this meta-analysis


Disclosure: P. Ungprasert, None; K. Wijarnpreecha, None; W. Cheungpasitporn, None.

To cite this abstract in AMA style:

Ungprasert P, Wijarnpreecha K, Cheungpasitporn W. Increased Risk of Cerebrovascular Accident Among Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review and Meta-Analysis of Cohort Studies [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/increased-risk-of-cerebrovascular-accident-among-patients-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-a-systematic-review-and-meta-analysis-of-cohort-studies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-cerebrovascular-accident-among-patients-with-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-a-systematic-review-and-meta-analysis-of-cohort-studies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology